New immune therapy tested for Tough-to-Treat cancers
NCT ID NCT05360680
Summary
This early-stage study tested a new immunotherapy drug called CUE-102 in patients with advanced colorectal, gastric, pancreatic, or ovarian cancer that had returned or spread after standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The treatment aims to guide the patient's own immune cells to attack cancer cells that carry a specific marker called WT1.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Carbone Cancer Center
Madison, Wisconsin, 53792, United States
-
Carol G. Simon Cancer Center - Morristown Medical Center
Morristown, New Jersey, 07960, United States
-
Carolina BioOncology Institute
Huntersville, North Carolina, 28078, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Cleveland Medical Center (University Hospitals)
Cleveland, Ohio, 44106, United States
-
Gabrail Cancer Center
Canton, Ohio, 44718, United States
-
Johns Hopkins University
Baltimore, Maryland, 21231, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Northwest Medical Specialties, PLLC
Tacoma, Washington, 98405, United States
-
Stanford Advanced Medicine Cancer Center
Palo Alto, California, 94304, United States
-
Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.